Delisted

Stopped trading. Last price we have: $0.0400 on Sep 27, 2024. Fund positions aren't valued until we confirm what happened.

EFTR

EFFECTOR THERAPEUTICS INC

EFTR·28202V207·US·Common Stock·Healthcare - Biotechnology

EFTR (EFFECTOR THERAPEUTICS INC) is held by 1 institutional investors as of Q3 2024. Largest holders: Blackstone Inc. ($2,041), BARCLAYS PLC ($4).

1
Holders
$4
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold EFTR.

Top Holders

Checking access…
Action
Unchanged
52,343$2,0410.0%—
0
Unchanged
100$40.0%—
0
Exited
0(-100.0%)$90.0%—
0
Exited
0(-100.0%)$3,2240.0%-86.21%
0
Exited
0(-100.0%)$7,4220.0%-99.69%
0
Exited
0(-100.0%)$700.0%-86.21%
0
Exited
0(-100.0%)$5,4160.0%-86.21%
0
Exited
0(-100.0%)$17,8830.0%-86.21%
0
Exited
0(-100.0%)$55,9360.0%-99.72%
0
Exited
0(-100.0%)$5,0000.0%-86.21%
0
Exited
0(-100.0%)$10.0%-99.72%
0
Exited
0(-100.0%)$6,0000.0%-86.21%
0
EFTREFTREFFECTOR THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used